The cold agglutinin disease drugs market is estimated to be valued at USD 164.6 Mn in 2025 and is expected to reach USD 693.1 Mn by 2032, growing at a compound annual growth rate (CAGR) of 22.8% from 2025 to 2032. https://gettr.com/post/p3lakqb6f5e